Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:5:p12
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 5 (pt 12/22)
Character Range: 281765–284686

in preparations for the prophylaxis of heartworm in cats and dogs; or
 (b) in intraruminal implants containing 160 mg or less of ivermectin; or
 (c) in preparations containing 3.5% or less of ivermectin when packed in child‑resistant packaging or in packaging approved by the relevant registration authority; or
 (d) in other preparations containing 2% or less of ivermectin.
KITASAMYCIN in animal feed premixes for growth promotion containing 2% or less of antibiotic substances.
LAMBDA‑CYHALOTHRIN:
 (a) in aqueous preparations containing 1% or less of lambda‑ cyhalothrin; or
 (b) in aqueous preparations containing 10% or less of microencapsulated lambda‑cyhalothrin.
LASIODIPLODIA PSEUDOTHEOBROMAE except when used as a herbicide in capsule preparations at a concentration of 16 CFU or less per capsule.
LEMON OIL except:
 (a) when steam distilled or rectified; or
 (b) in preparations for internal use; or
 (c) in preparations containing 0.05% or less of lemon oil; or
 (d) in soaps or bath or shower gels that are washed off the skin; or
 (e) in medicines for human therapeutic use, when compliant with the requirements of the required advisory statements for medicine labels; or
 (f) in other preparations when packed in containers labelled with the statement:

           Application to the skin may increase sensitivity to sunlight.
LEMONGRASS OIL in cosmetic and household cleaning preparations except in preparations containing 5% or less of 3,7‑dimethyl‑2,6‑octadienal.
LEVAMISOLE in preparations containing 15% or less of levamisole for the treatment of animals except:
 (a) when included in Schedule 4; or
 (b) in preparations for the treatment of ornamental birds or ornamental fish, in packs containing 10 mg or less of levamisole.
LIDOCAINE:
 (a) in aqueous gel preparations containing 4.5% or less of lidocaine, for the dermal spray‑on administration to the wounds of animals; or
 (b) in injectable preparations containing 2% or less of lidocaine when packaged in a container with a tamper resistant cartridge which can only be dispensed through a rubber ring applicator for tail docking and castration of lambs; or castration of calves.
LIME OIL except:
 (a) when steam distilled or rectified; or
 (b) in preparations for internal use; or
 (c) in preparations containing 0.5% or less of lime oil; or
 (d) in soaps or bath or shower gels that are washed off the skin; or
 (e) in medicines for human therapeutic use, when compliant with the requirements of the required advisory statements for medicine labels; or
 (f) in other preparations when packed in containers labelled with the statement:

           Application to the skin may increase sensitivity to sunlight.
LINDANE in preparations containing 10% or less of lindane except when included in Schedule 2 or 4.
LOTILANER.
LUFENURON except:
 (a) in divided preparations each containing 500 mg or less of lufenuron for the treatment of animals; or